0001572426-15-000129.txt : 20151120
0001572426-15-000129.hdr.sgml : 20151120
20151120131030
ACCESSION NUMBER: 0001572426-15-000129
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151120
FILED AS OF DATE: 20151120
DATE AS OF CHANGE: 20151120
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nexvet Biopharma plc
CENTRAL INDEX KEY: 0001618561
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: NATL INST FOR BIOPROCESSING RESEARCH
STREET 2: FOSTERS AVENUE, MOUNT MERRION
CITY: BLACKROCK CO. DUBLIN
STATE: L2
ZIP: 00000
BUSINESS PHONE: 353 1 215 8100
MAIL ADDRESS:
STREET 1: NATL INST FOR BIOPROCESSING RESEARCH
STREET 2: FOSTERS AVENUE, MOUNT MERRION
CITY: BLACKROCK CO. DUBLIN
STATE: L2
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: NEXVET BIOPHARMA Ltd
DATE OF NAME CHANGE: 20140903
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Heffernan Mark
CENTRAL INDEX KEY: 0001632439
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36828
FILM NUMBER: 151245942
MAIL ADDRESS:
STREET 1: C/O NEXVET BIOPHARMA PLC
STREET 2: NATL INST, FOSTERS AVENUE, MOUNT MERRION
CITY: BLACKROCK
STATE: L2
ZIP: 00000
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2015-11-20
0001618561
Nexvet Biopharma plc
NVET
0001632439
Heffernan Mark
C/O NEXVET BIOPHARMA PLC
NIBRT; FOSTERS AVENUE, MOUNT MERRION
BLACKROCK
L2
IRELAND
0
1
0
0
Chief Executive Officer
Ordinary Shares
2015-11-20
4
M
0
9204
.125
A
243587
I
By Mark Andrew and Patricia Louise Heffernan <M&T Heffernan A/C>
Ordinary Shares
12084
D
Option to Purchase Shares
.125
2015-11-20
4
M
0
9204
0
D
2020-11-05
Ordinary Shares
9204
9203
I
By Mark Andrew and Patricia Louise Heffernan <M&T Heffernan A/C>
The reporting person and his spouse share voting and dispositive power with respect to these reported securities.
Options to purchase 9,204 shares vested and became exercisable on 11/5/15, and the remaining 9,203 options to purchase shares will vest and become exercisable on 11/5/16.
/s/ Mark Heffernan by Geraldine T. Farrell, Attorney-in-Fact
2015-11-20